Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas

Fig. 2

CYB561D2 immunostaining is increased in gliomas. A Representative images of CYB561D2 staining in normal tissues, low-grade and high-grade gliomas. Scar bar = 50 µm. B Quantification of CYB561D2 staining by positive rate in normal tissues, low-grade and high-grade gliomas. C Quantification of CYB561D2 staining by Quickscore in normal tissues, low-grade and high-grade gliomas. Data were presented as mean ± SD. For all, *P < 0.05; **P < 0.01; ***P < 0.001. D Kaplan–Meier survival curves of patients classified by CYB561D2 expression in REMBRANDT gliomas dataset (total n = 524, HR = 2.06, P = 1.09e−8) and TCGA GBM dataset (total n = 454, HR = 1.47, P = 0.0011)

Back to article page